Dr. Harris E. Hawk, MD

Dr. Hawk practices at Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health.

Dr. Hawk's NPI, 1114131588, was assigned on May 9, 2007. Dr. Hawk graduated from Medical College of Georgia in 2006. Dr. Hawk holds Tennessee license 51225.

Dr. Hawk's primary practice is Erlanger Baroness Hospital, at 975 E 3rd St, Chattanooga, TN 37403 in Hamilton County. The practice phone is (423) 778-7000.

Dr. Hawk's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. Dr. Hawk is also affiliated with CommonSpirit - Memorial Hospital - Chattanooga. The medical group on file is Tennessee Interventional and Imaging Associates. Dmand AI also links Dr. Hawk to 2 more hospitals and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hawk practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Hawk's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Hawk is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Hawk's licenses on file in 6 states: Tennessee, Georgia, North Carolina, Alabama, South Carolina and Virginia.

CMS data shows 2,392 Medicare services from Dr. Hawk across 43 procedure codes in 2024, for 1,866 Medicare patients. Medicare paid $96,108 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,866 Medicare patients who saw Dr. Hawk in 2024. The largest group is 65 to 74, with 743 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hawk's median patient age at 67, with 58% women.

In 2024, Dr. Hawk wrote 125 Medicare Part D claims for 34 patients. 59% of them were for generic drugs. CMS names the drug for 111 of them, across 2 drugs with 11 or more claims each, at $24,702 in total drug cost. In 2023, CMS named 78 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Hawk for performance year 2024, reported as part of a group. Dr. Hawk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Hawk, published from 2012 to 2022. 2013 was the busiest year, with 3. The most frequent topics are Stroke, Thrombectomy and Brain Ischemia. Dr. Hawk has published most often in J Neurointerv Surg. Dr. Hawk's most frequent co-authors are Alejandro Marin Spiotta, MD, Blaise W. Baxter, MD and Mohammad I. Chaudry, MD.

Dmand AI links Dr. Hawk to 3 clinical trials. Conditions studied include Ischemic Stroke, Stroke and Intracranial Aneurysm.

CMS Open Payments shows 307 general payments to Dr. Hawk from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Penumbra, Inc. paid the most, $7,223.

Dr. Hawk graduated from Medical College of Georgia in 2006.

Dr. Hawk is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.